News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

5,744 Results

Type

Article (571)
Company Profile (2)
Press Release (5171)

Section

Business (1101)
Career Advice (6)
Deals (227)
Drug Development (535)
Employer Resources (1)
FDA (544)
Job Trends (103)
News (2503)
Policy (225)

Tag

Date

Today (3)
Last 7 days (8)
Last 30 days (30)
Last 365 days (273)
2025 (61)
2024 (293)
2023 (299)
2022 (375)
2021 (394)
2020 (332)
2019 (377)
2018 (286)
2017 (312)
2016 (319)
2015 (374)
2014 (282)
2013 (249)
2012 (265)
2011 (289)
2010 (275)

Location

Filters

Type

Article (571)
Company Profile (2)
Press Release (5171)

Section

Business (1101)
Career Advice (6)
Deals (227)
Drug Development (535)
Employer Resources (1)
FDA (544)
Job Trends (103)
News (2503)
Policy (225)

Tag

Date

Today (3)
Last 7 days (8)
Last 30 days (30)
Last 365 days (273)
2025 (61)
2024 (293)
2023 (299)
2022 (375)
2021 (394)
2020 (332)
2019 (377)
2018 (286)
2017 (312)
2016 (319)
2015 (374)
2014 (282)
2013 (249)
2012 (265)
2011 (289)
2010 (275)

Location

5,744 Results for "rhythm".

Sort By

Obesity

Rhythm Drug Leads to Reduced BMI in Rare Obesity Indication

Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the hypothalamus taking Rhythm Pharmaceuticals’ Imcivree.

April 7, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration

March 18, 2025
·
3 min read
Press Releases

Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.

March 21, 2025
·
7 min read
Press Releases

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan

March 20, 2025
·
9 min read
Press Releases

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity

April 7, 2025
·
8 min read
Press Releases

Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

March 28, 2025
·
6 min read
Press Releases

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

February 26, 2025
·
21 min read
Press Releases

Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February

February 5, 2025
·
6 min read
Press Releases

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity

April 7, 2025
·
13 min read
OMRON Healthcare’s Presence at Heart Rhythm 2024 in the U.S.

OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society in the U.S. At Heart Rhythm 2024, the Company will showcase its upper-arm blood pressure monitor with ECG technology, Complete, and a series of home-use blood pressure monitors.

May 17, 2024
·
3 min read

1 of 575

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin